Recent Updates
Recently added Catalysts
LTRN Neutral Sentiment

Lantern Pharma Reports Third Quarter 2026 Financial Results and Provides Business Updates

Key Takeaway: Lantern Pharma announced its financial results for the third quarter of 2026. The report includes business updates, although specific details were not provided in the announcement. The company continues to operate within its strategic framework and aims for future growth.

Market Sentiment Analysis

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+20%
120-day peak, hindsight
Typical move
5.6%
average across 3 past catalysts
Cash runway
~7 mo
High dilution risk
Lead asset
LP-300
Phase 2 · Adenocarcinoma of Lung

Full Press Release Details

DALLAS--(BUSINESS WIRE)--Lantern Pharma Reports Third Quarter 2026 Financial Results and Provides Business Updates

Frequently Asked Questions

What financial period did Lantern Pharma report?

Lantern Pharma reported its financial results for the third quarter of 2026.

What other updates were provided in the release?

The company also provided general business updates alongside the financial data.

Where is Lantern Pharma based?

The press release originated from Dallas, Texas.

What is the ticker symbol for Lantern Pharma?

Lantern Pharma trades under the ticker symbol LTRN on the stock market.

Last updated: Nov 18, 2026